Illumina Issues Second Shareholder Letter to Reject Roche | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – On the heels of Roche's extension of its hostile takeover bid and in anticipation of its annual shareholders' meeting next month, Illumina today sent a second letter to its shareholders to vote reject Roche's efforts to acquire the San Diego-based firm.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.